Target Name: LOC105374535
NCBI ID: G105374535
Review Report on LOC105374535 Target / Biomarker Content of Review Report on LOC105374535 Target / Biomarker
LOC105374535
Other Name(s): LOC105374535 variant X3 | uncharacterized LOC105374535 | Uncharacterized LOC105374535, transcript variant X3

LOC105374535: A Potential Drug Target and Biomarker

LOC105374535 is a gene that encodes a protein known as LOC105374535 (LOC105374535 variant X3). The protein is a key regulator of the immune response and has been implicated in a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. LOC105374535 is a variants of the gene that has been found to be associated with an increased risk of developing certain diseases. In this article, we will explore the potential implications of LOC105374535 as a drug target and biomarker.

Potential Drug Target

LOC105374535 has been shown to play a crucial role in the immune response and has been implicated in the development and progression of a number of diseases. One of the most promising aspects of LOC105374535 is its potential as a drug target. By targeting this protein, researchers may be able to develop new treatments for a variety of diseases.

For example, LOC105374535 has been shown to be involved in the development of cancer. In fact, studies have suggested that LOC105374535 may be a key regulator of cancer cell growth and survival. By targeting this protein, researchers may be able to develop new treatments for cancer, including targeted therapies and immunotherapies.

Another potential drug target for LOC105374535 is its role in neurodegenerative diseases. LOC105374535 has been implicated in the development and progression of a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. By targeting this protein, researchers may be able to develop new treatments for these diseases and improve quality of life for patients.

Biomarker

LOC105374535 has also been shown to be a potential biomarker for a number of diseases. For example, studies have suggested that LOC105374535 may be involved in the development of cancer, including ovarian cancer. In addition, LOC105374535 has been shown to be involved in the development of autoimmune disorders, such as rheumatoid arthritis and lupus.

By studying the role of LOC105374535 in these diseases, researchers may be able to develop new diagnostic tests and treatments. For example, by using techniques such as mass spectrometry, researchers may be able to identify biomarkers that can be used to diagnose and monitor the progression of cancer. In addition, researchers may be able to use these biomarkers to develop new treatments for cancer, including targeted therapies and immunotherapies.

Conclusion

LOC105374535 is a gene that has the potential to be a drug target and biomarker. Its role in the immune response and its association with a variety of diseases make it an attractive target for researchers. By studying the role of LOC105374535 in these diseases, researchers may be able to develop new treatments for a variety of conditions and improve quality of life for patients.

Overall, LOC105374535 is a promising gene that has the potential to be a valuable tool for the development of new treatments for a variety of diseases. Further research is needed to fully understand its role and potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105374535

The "LOC105374535 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374535 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381